Data under review. Our nightly checks found a problem in this company's reported figures on Oct 23, 2026, so we are not showing its score, ratios or statements for now. The figures come back after they pass the checks two nights in a row. The price and chart are live.
Abivax (ABVX) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.
85,000 Shares of Abivax SA Sponsored ADR $ABVX Acquired by ACT Capital Partners L.P.
ACT Capital Partners L.P. acquired a new position in shares of Abivax SA Sponsored ADR (NASDAQ: ABVX) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institu…
● GlobeNewsWireNov 2, 2026 · 16:05 ETCOMPANY'S OWN WORDS
Abivax to Participate in Upcoming Fall Investor Conferences
Abivax to Participate in Upcoming Fall Investor Conferences PARIS, France – November 2, 2026 – 10:05 PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage b…
Abivax: Priced Right Ahead Of 2 Make-Or-Break Catalysts
Abivax Société Anonyme is advancing obefazimod for ulcerative colitis and Crohn's, with recent safety concerns now largely addressed. ABVX raised $920 million, extending its cash runway into Q4 2029 and strengthening its…
● GlobeNewsWireSep 21, 2026 · 16:05 ETCOMPANY'S OWN WORDS
Abivax Presents Business Updates and First Half 2026 Financial Results
Abivax Presents Business Updates and First Half 2026 Financial Results Chris Rabbat to succeed Fabio Cataldi as Chief Medical Officer; Tim Kelly appointed Chief Technical Officer to advance commercial supply readiness a…
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Average Rating of “Moderate Buy” by Brokerages
Abivax SA Sponsored ADR (NASDAQ: ABVX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the sixteen research firms that are currently covering the company, MarketBeat.com reports. One equities res…
Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's Why
Abivax SA Sponsored ADR (ABVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).…
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Average Recommendation of “Moderate Buy” by Brokerages
Shares of Abivax SA Sponsored ADR (NASDAQ: ABVX - Get Free Report) have received an average rating of "Moderate Buy" from the fifteen brokerages that are presently covering the stock, Marketbeat reports. One research ana…
Article counts from the last market-wide feed page, across every symbol we track and not just ABVX · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.
The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.